Common fruit found in American kitchens may slow deadly form of breast cancer, study saysCommon fruit found in American kitchens may slow deadly form of breast cancer, study says
Scientists recently found that dark sweet cherries may help slow aggressive triple-negative breast cancer growth in mice, according to research from Texas A&M University.
STAT+: Novo Nordisk’s Wegovy and Ozempic shots could be made for as little as $3 a month, analysis findsSTAT+: Novo Nordisk’s Wegovy and Ozempic shots could be made for as little as $3 a month, analysis finds
Generic versions of Novo Nordisk’s blockbuster Wegovy and Ozempic medications could be mass produced for about $3 per person a month, a cost that could greatly widen access in low- and middle-income countries, according to a new analysis. After reviewing data for active pharmaceutical ingredients from the past two years, the researchers estimated a generic Read More
Anti-obesity treatment could cost as little as $3 per month: StudyAnti-obesity treatment could cost as little as $3 per month: Study
A blockbuster anti-obesity and diabetes drug could cost as little as $3 per month to manufacture once it goes off patent later this month, researchers said Friday, providing a major opportunity to boost health in low- and middle-income countries.
MRI supplemental to digital breast tomosynthesis averts additional breast cancer deathsMRI supplemental to digital breast tomosynthesis averts additional breast cancer deaths
For women aged 40 years and older with extremely dense breasts, digital breast tomosynthesis (DBT) with supplemental magnetic resonance imaging (MRI) averts additional breast cancer deaths and results in more false-positive biopsy recommendations, according to a study published online March 2 in Annals of Internal Medicine.
‘Game-changing’ urine tests could detect breast cancer, endometriosis and PCOS’Game-changing’ urine tests could detect breast cancer, endometriosis and PCOS
New tests are being developed to spot early signs of breast cancer and endometriosis in urine.
GLP-1 drugs like Ozempic can curb addiction risk, study findsGLP-1 drugs like Ozempic can curb addiction risk, study finds
A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose. A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.
Trial suggests GLP-1 combo therapy cuts fat while preserving muscle in obesityTrial suggests GLP-1 combo therapy cuts fat while preserving muscle in obesity
A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks activin signaling pathways, results in greater weight loss while also preserving lean mass, such as skeletal muscle and connective tissue. In the paper “Bimagrumab and semaglutide alone or in combination for the treatment of obesity: Read More
STAT+: Omada reports first profitable quarter as it seizes broad GLP-1 opportunitySTAT+: Omada reports first profitable quarter as it seizes broad GLP-1 opportunity
Digital chronic care company Omada reported a quarterly profit for the first time since going public less than a year ago, the company revealed while announcing its full year 2025 earnings Thursday. Omada also provided earnings guidance for 2026, suggesting the company will continue to grow as it capitalizes on the demand for popular GLP-1 Read More
GLP-1 Drugs May Prevent, Treat Multiple AddictionsGLP-1 Drugs May Prevent, Treat Multiple Addictions
(MedPage Today) — Initiation of a GLP-1 receptor agonist was tied to lower risks of several substance use disorders (SUDs) in adults with type 2 diabetes, according to a target trial emulation using data on veterans. In patients without a history… (MedPage Today) — Initiation of a GLP-1 receptor agonist was tied to lower Read More
Ozempic-style drugs could slash complication risks after heart attacks, research suggestsOzempic-style drugs could slash complication risks after heart attacks, research suggests
A popular class of weight-loss drugs may prevent life-threatening cardiac complications by opening microscopic blood vessels that often remain blocked after a heart attack, according to a study published this week in Nature Communications. The research, led by the University of Bristol and University College London, identified a biological brain-gut-heart signaling pathway. This discovery appears Read More